Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

September 2011; Volume 31,Issue 9

Experimental Studies

  • You have access
    Gankyrin, A Biomarker for Epithelial Carcinogenesis, Is Overexpressed in Human Oral Cancer
    JUNAN LI, THOMAS J. KNOBLOCH, LAURA A. KRESTY, ZHAOXIA ZHANG, JAS C. LANG, DAVID E. SCHULLER and CHRISTOPHER M. WEGHORST
    Anticancer Research September 2011, 31 (9) 2683-2692;
  • You have access
    Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue
    V. YAGUBLU, J.R. ARTHUR, S.N. BABAYEVA, F. NICOL, S. POST and M. KEESE
    Anticancer Research September 2011, 31 (9) 2693-2698;
  • You have access
    Pomegranate Extract Induces Cell Cycle Arrest and Alters Cellular Phenotype of Human Pancreatic Cancer Cells
    VIDHYA NAIR, ZHAOLI DAI, MARUF KHAN and HENRY P. CIOLINO
    Anticancer Research September 2011, 31 (9) 2699-2704;
  • You have access
    6-Thioguanine Inhibition of Parathyroid Hormone-related Protein Expression Is Mediated by GLI2
    RACHELLE W. JOHNSON, ALYSSA R. MERKEL, SABRINA DANILIN, MAI P. NGUYEN, GREGORY R. MUNDY and JULIE A. STERLING
    Anticancer Research September 2011, 31 (9) 2705-2712;
  • You have access
    The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to the Cytotoxic Effect of Carboplatin in Breast Cancer In Vitro
    HONGYU LIU, CHUANBING ZANG, JAN-HENDRIK SCHEFE, SANDRA SCHWARZLOSE-SCHWARCK, ANNE-CONSTANZE REGIERER, ELENA ELSTNER, CARSTEN-OLIVER SCHULZ, CHRISTIAN SCHOLZ, KURT POSSINGER and JAN EUCKER
    Anticancer Research September 2011, 31 (9) 2713-2722;
  • You have access
    Histone Deacetylase Inhibitors Reverse CpG Methylation by Regulating DNMT1 through ERK Signaling
    SIBAJI SARKAR, ANA L. ABUJAMRA, JENNY E. LOEW, LORA W. FORMAN, SUSAN P. PERRINE and DOUGLAS V. FALLER
    Anticancer Research September 2011, 31 (9) 2723-2732;
  • You have access
    Protein-bound Polysaccharide-K (PSK) Induces Apoptosis and Inhibits Proliferation of Promyelomonocytic Leukemia HL-60 Cells
    NORIYUKI HIRAHARA, MASAKI FUJIOKA, TAKEO EDAMATSU, AYAKO FUJIEDA, FUJIO SEKINE, TSUTOMU WADA and TSUNEO TANAKA
    Anticancer Research September 2011, 31 (9) 2733-2738;
  • You have access
    Clioquinol Suppresses Cyclin D1 Gene Expression through Transcriptional and Post-transcriptional Mechanisms
    JIE ZHENG, DORIS M. BENBROOK, HAIJUN YU and WEI-QUN DING
    Anticancer Research September 2011, 31 (9) 2739-2747;
  • You have access
    Prognostic Relevance of Disseminated Tumor Cells in the Bone Marrow of Patients with Primary Breast Cancer – Results of a Standardized Follow-Up
    C. SCHINDLBECK, G. PFAB, J. JUECKSTOCK, U. ANDERGASSEN, H. SOMMER, W. JANNI, K. FRIESE and B. RACK
    Anticancer Research September 2011, 31 (9) 2749-2755;
  • You have access
    Modulation of Cisplatin Cytotoxicity due to its Combination with Bortezomib and the Nature of its Administration
    ZAYNAB AL-EISAWI, PHILIP BEALE, CHARLES CHAN, JUN QING YU and FAZLUL HUQ
    Anticancer Research September 2011, 31 (9) 2757-2762;
  • You have access
    Prognostic Significance of Thymidylate Synthase Expression in the Adjuvant Chemotherapy after Resection for Pulmonary Metastases from Colorectal Cancer
    KYOICHI KAIRA, TAKEHIRO OKUMURA, YASUHISA OHDE, TOSHIAKI TAKAHASHI, HARUYASU MURAKAMI, HARUHIKO KONDO, TAKASHI NAKAJIMA and NOBUYUKI YAMAMOTO
    Anticancer Research September 2011, 31 (9) 2763-2771;
  • You have access
    In Vitro and In Vivo Anticancer Activity of (+)-Spongistatin 1
    QUNLI XU, KUAN-CHUN HUANG, KAREN TENDYKE, JOANNE MARSH, JUNKE LIU, DAYONG QIU, BRUCE A. LITTLEFIELD, KENICHI NOMOTO, ONUR ATASOYLU, CHRISTINA A. RISATTI, JEFFREY B. SPERRY and AMOS B. SMITH
    Anticancer Research September 2011, 31 (9) 2773-2779;
  • You have access
    Interaction of Dacarbazine and Imexon, In Vitro and In Vivo, in Human A375 Melanoma Cells
    BETTY K. SAMULITIS, ROBERT T. DORR and H-H. SHERRY CHOW
    Anticancer Research September 2011, 31 (9) 2781-2785;
  • You have access
    Acquired Drug Resistance to Vascular Endothelial Growth Factor Receptor 2 Tyrosine Kinase Inhibitor in Human Vascular Endothelial Cells
    TOKUZO ARAO, KAZUKO MATSUMOTO, KAZUYUKI FURUTA, KANAE KUDO, HIROYASU KANEDA, TOMOYUKI NAGAI, KAZUKO SAKAI, YOSHIHIKO FUJITA, DAISUKE TAMURA, KEIICHI AOMATSU, FUMIAKI KOIZUMI and KAZUTO NISHIO
    Anticancer Research September 2011, 31 (9) 2787-2796;
  • You have access
    SDF1β Expression in Renal Cell Carcinoma Correlates with Grading and Infiltration by CD8+ T-Cells
    T.C. WEHLER, C. GRAF, K. ALTHERR, T. ZIMMERMANN, W. BRENNER, J.W. THÜROFF, S. BIESTERFELD, I. GOCKEL, M. THEOBALD, P.R. GALLE and C.C. SCHIMANSKI
    Anticancer Research September 2011, 31 (9) 2797-2803;
  • You have access
    Activation of the Wnt/Beta-catenin Signaling Pathway during Oral Carcinogenesis Process Is Not Influenced by the Absence of Galectin-3 in Mice
    JULIANA MOREIRA DE ALMEIDA SANT'ANA, ROGER CHAMMAS, FU-TONG LIU, SUELY NONOGAKI, SÉRGIO VITORINO CARDOSO, ADRIANO MOTA LOYOLA and PAULO ROGÉRIO DE FARIA
    Anticancer Research September 2011, 31 (9) 2805-2811;
  • You have access
    Anti-MDR1 siRNA Restores Chemosensitivity in Chemoresistant Breast Carcinoma and Osteosarcoma Cell Lines
    JENNIFER PEREZ, CHRISTINE BARDIN, CHANTAL RIGAL, BESSE ANTHONY, RAPHAËL ROUSSEAU and AURELIE DUTOUR
    Anticancer Research September 2011, 31 (9) 2813-2820;
  • You have access
    Gallic Acid Induces G0/G1 Phase Arrest and Apoptosis in Human Leukemia HL-60 Cells through Inhibiting Cyclin D and E, and Activating Mitochondria-dependent Pathway
    RU-DUAN YEH, JUNG-CHOU CHEN, TUNG-YUAN LAI, JAI-SING YANG, CHUN-SHU YU, JO-HUA CHIANG, CHI-CHENG LU, SU-TSO YANG, CHIEN-CHIH YU, SHU-JEN CHANG, HUI-YI LIN and JING-GUNG CHUNG
    Anticancer Research September 2011, 31 (9) 2821-2832;
  • You have access
    Correlation between Expression of Metallothionein and Expression of Ki-67 and MCM-2 Proliferation Markers in Non-Small Cell Lung Cancer
    BOZENA WERYNSKA, BARTOSZ PULA, BEATA MUSZCZYNSKA-BERNHARD, ALEKSANDRA PIOTROWSKA, ALEKSANDRA JETHON, MARZENA PODHORSKA-OKOLOW, PIOTR DZIEGIEL and RENATA JANKOWSKA
    Anticancer Research September 2011, 31 (9) 2833-2839;
  • You have access
    Evaluation of Anticancer Activities of Benzo[c]phenanthridine Alkaloid Sanguinarine in Oral Squamous Cell Carcinoma Cell Line
    HIKARI TSUKAMOTO, SEIJI KONDO, YOSHIKI MUKUDAI, TATSUHITO NAGUMO, ARISA YASUDA, YUJI KURIHARA, TAKAAKI KAMATANI and SATORU SHINTANI
    Anticancer Research September 2011, 31 (9) 2841-2846;
  • You have access
    Interaction of Radiation and Pemetrexed on a Human Malignant Mesothelioma Cell Line In Vitro
    DAISAKU YOSHIDA, TAKESHI EBARA, YUMI SATO, TAKUYA KAMINUMA, TAKEO TAKAHASHI, TAKAYUKI ASAO and TAKASHI NAKANO
    Anticancer Research September 2011, 31 (9) 2847-2851;
  • You have access
    Antitumor Therapeutic Effects of Cytosine Deaminase and Interferon-β Against Endometrial Cancer Cells Using Genetically Engineered Stem Cells In Vitro
    BO-RIM YI, NAM-HEE KANG, KYUNG-A HWANG, SEUNG U. KIM, EUI-BAE JEUNG and KYUNG-CHUL CHOI
    Anticancer Research September 2011, 31 (9) 2853-2861;
  • You have access
    Determination of Clofarabine Triphosphate Concentrations in Leukemia Cells Using Sensitive, Isocratic High-performance Liquid Chromatography
    TAKAHIRO YAMAUCHI, RIE NISHI and TAKANORI UEDA
    Anticancer Research September 2011, 31 (9) 2863-2867;
  • You have access
    H-ras Up-regulates Expression of BNIP3
    WOJCIECH KALAS, EWELINA SWIDEREK, ANDRZEJ RAPAK, MAGDALENA KOPIJ, JANUSZ RAK and LEON STRZADALA
    Anticancer Research September 2011, 31 (9) 2869-2875;
  • You have access
    K-ras Mutations in Lung Tumors from NNK-treated Mice with Lipopolysaccharide-elicited Lung Inflammation
    PHOUTHONE KEOHAVONG, BETH KAHKONEN, EDWINA KINCHINGTON, JINLING YIN, JIDE JIN, XIAOPING LIU, JILL M. SIEGFRIED and Y. PETER DI
    Anticancer Research September 2011, 31 (9) 2877-2882;
  • You have access
    Prediction of Synergistic Antitumour Effect of Gefitinib and Radiation In Vitro
    HUI QIANG LIN, HAIDER MERIATY and ANDREW KATSIFIS
    Anticancer Research September 2011, 31 (9) 2883-2888;
  • You have access
    Methylation of the Homeobox Gene, HOPX, Is Frequently Detected in Poorly Differentiated Colorectal Cancer
    YOSHIKUNI HARADA, KAZUHIRO KIJIMA, KAZUKI SHINMURA, MAKIKO SAKATA, KAZUMA SAKURABA, KAZUAKI YOKOMIZO, YOUHEI KITAMURA, ATSUSHI SHIRAHATA, TETSUHIRO GOTO, HIROKI MIZUKAMI, MITSUO SAITO, GAKU KIGAWA, HIROSHI NEMOTO and KENJI HIBI
    Anticancer Research September 2011, 31 (9) 2889-2892;
  • You have access
    Etodolac Improves 5-FU Sensitivity of Head and Neck Cancer Cells through Inhibition of Thymidylate Synthase
    SHOGO MURATA, MAKOTO ADACHI, MITOMU KIOI, SOICHIRO TORIGOE, KEI IJICHI, YASUHISA HASEGAWA, TETSUYA OGAWA, MIHIR K. BHAYANI, STEPHEN Y. LAI, KENJI MITSUDO and IWAI TOHNAI
    Anticancer Research September 2011, 31 (9) 2893-2898;
  • You have access
    Down-regulation of Expression of Interleukin-6 and its Receptor Results in Growth Inhibition of MCF-7 Breast Cancer Cells
    XIAN-PENG JIANG, DING CHENG YANG, ROBERT L. ELLIOTT and JONATHAN F. HEAD
    Anticancer Research September 2011, 31 (9) 2899-2906;
  • You have access
    Comparison of μCT, MRI and Optical Reflectance Imaging for Assessing the Growth of GFP/RFP-expressing Tumors
    LOTFI ABOU-ELKACEM, FELIX GREMSE, STEFAN BARTH, ROBERT M. HOFFMAN, FABIAN KIESSLING and WILTRUD LEDERLE
    Anticancer Research September 2011, 31 (9) 2907-2913;
  • You have access
    Panipenem Does Not Alter the Pharmacokinetics of the Active Metabolite of Irinotecan SN-38 and Inactive Metabolite SN-38 Glucuronide (SN-38G) in Rats
    AYAKO KATO, JUN UEYAMA, FUMIE ABE, KAZUO HOTTA, IKUTO TSUKIYAMA, TAEYUKI OSHIMA, FUMIO KONDO, HIROKO SAITO and TAKAAKI HASEGAWA
    Anticancer Research September 2011, 31 (9) 2915-2922;

Clinical Studies

  • You have access
    CT and MR Imaging of the Adrenal Glands in Cortisol-secreting Tumors
    FRANCO LUMACHI, PAOLO MARCHESI, DIEGO MIOTTO and RAFFAELLA MOTTA
    Anticancer Research September 2011, 31 (9) 2923-2926;
  • You have access
    Cryotreatment against Metastatic Renal Cell Bone Tumour Reduced Multiple Lung Metastases
    HIDEJI NISHIDA, TOSHIHARU SHIRAI, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, YOSHIKAZU TANZAWA, ATSUSHI MIZOKAMI, MIKIO NAMIKI and HIROYUKI TSUCHIYA
    Anticancer Research September 2011, 31 (9) 2927-2930;
  • You have access
    Nonhepatic Cancer in Liver Cirrhosis: A Retrospective Study of Prevalence, Complication Rate after Specific Oncological Treatment, Follow-up and Prognostic Predictors of Outcome in 354 Patients with Cirrhosis
    FELIX GUNDLING, HOLGER SEIDL, FABIAN SCHMIDTLER, NICOLA LÖFFLER, INGRID STRASSEN, PETRA WOLF, CHRISTIAN PEHL, THOMAS SCHMIDT and WOLFGANG SCHEPP
    Anticancer Research September 2011, 31 (9) 2931-2938;
  • You have access
    Serum 25-Hydroxyvitamin D and Prevention of Breast Cancer: Pooled Analysis
    SHARIF B. MOHR, EDWARD D. GORHAM, JOHN E. ALCARAZ, CHRISTOPHER J. KANE, CAROLINE A. MACERA, J. KELLOGG PARSONS, DEBORAH L. WINGARD and CEDRIC F. GARLAND
    Anticancer Research September 2011, 31 (9) 2939-2948;
  • You have access
    Basic Clinical Parameters Predict Gefitinib Efficacy in Non-small Cell Lung Cancer
    ANDREAS PIRCHER, ERNST ULSPERGER, RENE HACK, HERBERT JAMNIG, GEORG PALL, BETTINA ZELGER, WILLIAM STERLACCI, WOLFGANG HILBE and MICHAEL FIEGL
    Anticancer Research September 2011, 31 (9) 2949-2955;
  • You have access
    Palladin is a Marker of Liver Metastasis in Primary Pancreatic Endocrine Carcinomas
    EVITA B. HENDERSON-JACKSON, JAMES HELM, JONATHAN STROSBERG, NELLY A. NASIR, TIMOTHY J. YEATMAN, LARRY K. KVOLS, DOMENICO COPPOLA and AEJAZ NASIR
    Anticancer Research September 2011, 31 (9) 2957-2962;
  • You have access
    Elevated YB-1 Expression is a New Unfavorable Prognostic Factor in Non-Hodgkin's Lymphomas
    KATARZYNA SZCZURASZEK, AGNIESZKA HALON, VERENA MATERNA, GRZEGORZ MAZUR, TOMASZ WROBEL, KAZIMIERZ KULICZKOWSKI, PIOTR DONIZY, PER S. HOLM, HERMANN LAGE and PAWEL SUROWIAK
    Anticancer Research September 2011, 31 (9) 2963-2970;
  • You have access
    The Efficacy of Gemcitabine as Salvage Treatment in Patients with Refractory Advanced Colorectal Cancer (CRC): A Single Institution Experience
    MUHAMMAD WASIF SAIF, KRISTIN KALEY, ROBIN PENNEY, SUSAN HOTCHKISS, KOSTAS N. SYRIGOS and ALEXIOS S. STRIMPAKOS
    Anticancer Research September 2011, 31 (9) 2971-2974;
  • You have access
    RASSF1A Methylation is Predictive of Poor Prognosis in Female Breast Cancer in a Background of Overall Low Methylation Frequency
    ABDELBASET BUHMEIDA, ADNAN MERDAD, JOUDAH EL-MAGHRABI, FATIMA AL-THOBAITI, MANAR ATA, AYMAN BUGIS, KARI SYRJÄNEN, ADEL ABUZENADAH, ADEEL CHAUDHARY, MAMDOOH GARI, MOHAMMED AL-QAHTANI and ASHRAF DALLOL
    Anticancer Research September 2011, 31 (9) 2975-2981;
  • You have access
    Safety and Short-term Therapeutic Effects of Miriplatin–Lipiodol Suspension in Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma
    KAZUTOSHI OKABE, TORU BEPPU, KATSUKI HARAOKA, YOSHIHIRO OH-UCHIDA, SADAHIRO YAMAMURA, SHINJIRO TOMIYASU, TSUYOSHI YAMANAKA, OSAMU SANO, TOSHIRO MASUDA, AKIRA CHIKAMOTO, SHIGETOSHI FUJIYAMA and HIDEO BABA
    Anticancer Research September 2011, 31 (9) 2983-2988;
  • You have access
    A Low-grade Myofibroblastic Sarcoma in the Abdominal Cavity
    MIKI MIYAZAWA, YOSHIHIKO NARITAKA, AKIRA MIYAKI, SHINICHI ASAKA, NORIYUKI ISOHATA, KENTARO YAMAGUCHI, MINORU MURAYAMA, TAKESHI SHIMAKAWA, TAKAO KATSUBE, KENJI OGAWA and MARIKO FUJIBAYASHI
    Anticancer Research September 2011, 31 (9) 2989-2994;
  • You have access
    Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Non-small Cell Lung Cancer
    MASAKI TOMITA, TETSUYA SHIMIZU, TAKANORI AYABE, AKIHIRO YONEI and TOSHIO ONITSUKA
    Anticancer Research September 2011, 31 (9) 2995-2998;
  • You have access
    Lapatinib Enhances Herceptin-mediated Antibody-dependent Cellular Cytotoxicity by Up-regulation of Cell Surface HER2 Expression
    TAKANORI MARUYAMA, KOUSAKU MIMURA, SHINICHIRO IZAWA, AYAKO INOUE, SHUGO SHIBA, MITSUAKI WATANABE, YOSHIHIKO KAWAGUCHI, MASAYUKI INOUE, HISASHI NOGATA, SHINGO INOUE, HIDEKI FUJII and KOJI KONO
    Anticancer Research September 2011, 31 (9) 2999-3005;
  • You have access
    Paclitaxel and Bevacizumab as First Line Combined Treatment in Patients with Metastatic Breast Cancer: The Hellenic Cooperative Oncology Group Experience with Biological Marker Evaluation
    GEORGE FOUNTZILAS, HELEN P. KOUREA, MATTHEOS BOBOS, DESPINA TELEVANTOU, VASSILIKI KOTOULA, CHRISTOS PAPADIMITRIOU, KONSTANTINOS T. PAPAZISIS, ELENI TIMOTHEADOU, IOANNIS EFSTRATIOU, ANGELOS KOUTRAS, GEORGE PENTHEROUDAKIS, CHRISTOS CHRISTODOULOU, GERASSIMOS ARAVANTINOS, DIMOSTHENIS MILIARAS, KALLIOPI PETRAKI, CHRISTOS N. PAPANDREOU, PAVLOS PAPAKOSTAS, DIMITRIOS BAFALOUKOS, DIMITRA REPANA, EVANGELIA RAZIS, DIMITRIOS PECTASIDES and ATHANASSIOS M. DIMOPOULOS
    Anticancer Research September 2011, 31 (9) 3007-3018;
  • You have access
    Differential Activation of MAPK and PI3K/AKT/mTOR Pathways and IGF1R Expressionin Gastrointestinal Stromal Tumors
    M.J. RÍOS-MORENO, S. JARAMILLO, M. DÍAZ-DELGADO, M. SÁNCHEZ-LEÓN, I. TRIGO-SÁNCHEZ, J. POLO PADILLO, J. AMÉRIGO and R. GONZÁLEZ-CÁMPORA
    Anticancer Research September 2011, 31 (9) 3019-3025;
  • You have access
    Correlation of Intensity of MT-I/II Expression with Ki-67 and MCM-2 Proteins in Invasive Ductal Breast Carcinoma
    ANDRZEJ WOJNAR, BARTOSZ PULA, ALEKSANDRA PIOTROWSKA, ALEKSANDRA JETHON, KRZYSZTOF KUJAWA, CHRISTOPHER KOBIERZYCKI, JANUSZ RYS, MARZENA PODHORSKA-OKOLOW and PIOTR DZIEGIEL
    Anticancer Research September 2011, 31 (9) 3027-3033;
  • You have access
    Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
    TAKAHIRO NAKAYAMA, SATOSHI MORITA, TSUTOMU TAKASHIMA, SHUNJI KAMIGAKI, KATSUHIDE YOSHIDOME, TOSHIKAZU ITO, TETSUYA TAGUCHI, JUNICHI SAKAMOTO and SHINZABURO NOGUCHI
    Anticancer Research September 2011, 31 (9) 3035-3039;
  • You have access
    Pathological Complete Response and Prognosis in Patients Receiving Neoadjuvant Paclitaxel and Trastuzumab with and without Anthracyclines for Stage II and III, HER2-positive Operable Breast Cancer: A Single-institute Experience
    JUN HORIGUCHI, TETSUNARI OYAMA, DAISUKE TAKATA, NANA ROKUTANDA, RIN NAGAOKA, HIROKI ODAWARA, HIDEAKI TOKINIWA, KATSUNORI TOZUKA, MAMI KIKUCHI, AYAKO SATO and IZUMI TAKEYOSHI
    Anticancer Research September 2011, 31 (9) 3041-3046;
  • You have access
    Fertility-sparing Management of Grade 2 and 3 Endometrial Adenocarcinomas
    MARTIN KOSKAS, CHADI YAZBECK, FRANCINE WALKER, ELODIE CLOUQUEUR, AUBERT AGOSTINI, SANDRINE RUAT, JEAN PHILIPPE LUCOT, ERIC LAMBAUDIE, DOMINIQUE LUTON and PATRICK MADELENAT
    Anticancer Research September 2011, 31 (9) 3047-3049;
  • You have access
    Effect of Glutathione-S-Transferase M1 and T1 Allelic Polymorphisms on HPV-induced Cervical Precancer Formation
    JÓZSEF CSEH, EMESE PÁZSIT, ZSUZSA ORSÓS, ERIKA MAREK, ANDRÁS HUSZÁR, SÁNDOR BALOGH, ISTVÁN EMBER and ISTVÁN KISS
    Anticancer Research September 2011, 31 (9) 3051-3055;
  • You have access
    Gene Polymorphisms MTHFRC677T and MTRA2756G as Predictive Factors in Adjuvant Chemotherapy for Stage III Colorectal Cancer
    HELENA TAFLIN, YVONNE WETTERGREN, ELISABETH ODIN, GÖRAN CARLSSON and KRISTOFFER DERWINGER
    Anticancer Research September 2011, 31 (9) 3057-3062;
  • You have access
    Evaluation of Oral Etoposide in Combination with Cisplatin for Patients with Recurrent Cervical Cancer: Long-term Follow-up Results of a Japanese Multicenter Study
    YOH WATANABE, HIROSHI HOSHIAI, TORU NAKANISHI, NAOKI KAWAMURA, NAOTAKE TANAKA, KEIICHI ISAKA, SHOJI KAMIURA, MASAHIDE OHMICHI, MASAYUKI HATAE and KAZUNORI OCHIAI
    Anticancer Research September 2011, 31 (9) 3063-3067;
  • You have access
    Pleomorphic Ductal Carcinoma of the Male Breast: Report of a Rare Case and Review of Literature
    ROSARIO CARUSO, RENATO PALMERI, SERGIO RACCHIUSA, ANNA BONANNO, ROBERTA LUCIANÒ, MARCO SCARDIGNO, GIOVANNI BRANCA and FRANCESCO FEDELE
    Anticancer Research September 2011, 31 (9) 3069-3071;
  • You have access
    Neoadjuvant Chemoradiotherapy for Clinical Stage II-III Esophageal Squamous Cell Carcinoma
    HIROSHI SAEKI, MASARU MORITA, YUICHIRO NAKASHIMA, HIDETO SONODA, KENKICHI HASHIMOTO, AKINORI EGASHIRA, EIJI OKI, TAKEFUMI OHGA, YOSHIHIRO KAKEJI and YOSHIHIKO MAEHARA
    Anticancer Research September 2011, 31 (9) 3073-3077;
  • You have access
    Phase I Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Resectable Advanced Gastric Cancer (KOGC-01)
    TSUNEHIRO TAKAHASHI, YOSHIRO SAIKAWA, HIROMASA TAKAISHI, HIROYA TAKEUCHI, NORIHITO WADA, TAKASHI OYAMA, KAZUMASA FUKUDA, JUNICHI FUKADA, OSAMU KAWAGUCHI, NAOYUKI SHIGEMATSU and YUKO KITAGAWA
    Anticancer Research September 2011, 31 (9) 3079-3083;
  • You have access
    Feasibility Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 for Advanced Gastric Cancer
    KAZUMASA FUJITANI, HIROKO HASEGAWA, MOTOHIRO HIRAO, YUKINORI KUROKAWA and TOSHIMASA TSUJINAKA
    Anticancer Research September 2011, 31 (9) 3085-3091;
  • You have access
    Evaluation of Kallikrein-related Peptidase 5 Expression and its Significance for Breast Cancer Patients: Association with Kallikrein-related Peptidase 7 Expression
    MAROULIO TALIERI, MARINA DEVETZI, ANDREAS SCORILAS, PANAGIOTIS PREZAS, ALEXANDROS ARDAVANIS, AIKATERINI APOSTOLAKI and ANDREAS KARAMERIS
    Anticancer Research September 2011, 31 (9) 3093-3100;
  • You have access
    Sifneos Alexithymia Questionnaire in Assessment of General Alexithymia in Patients with Breast Disease and Breast Cancer: A Prospective Case–Control Study in Finland
    MATTI ESKELINEN and PAULA OLLONEN
    Anticancer Research September 2011, 31 (9) 3101-3106;
  • You have access
    The Role of MonoTotal in the Primary Diagnosis, Prognosis and Follow-up of Patients with Non-small Cell Lung Cancer (NSCLC)
    MARKETA PRAZAKOVA, JINDRA VRZALOVA, JOSEP MARIA AUGE, JARMIL SAFRANEK, ONDREJ TOPOLCAN, RADKA FUCHSOVA, MARKETA SPISAKOVA, SARKA SVOBODOVA, LUBOS HOLUBEC and MARTIN PESTA
    Anticancer Research September 2011, 31 (9) 3107-3112;
  • You have access
    Erratum
    Anticancer Research September 2011, 31 (9) 3113;
Back to top
PreviousNext

In this issue

Anticancer Research: 31 (9)
Anticancer Research
Vol. 31, Issue 9
September 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire